{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:01:12Z","timestamp":1793944872364,"version":"4.8.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"HEALIOS K.K."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04461-9","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:20:18Z","timestamp":1752538818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity"],"prefix":"10.1186","volume":"16","author":[{"given":"Yuma","family":"Fukutani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kurachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-suke","family":"Torisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotoko","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodai","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sono","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudai","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Naritomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Uesugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Tsuneyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusako","family":"Nishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9190-3659","authenticated-orcid":false,"given":"Hironobu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"5","key":"4461_CR1","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/sj.bjc.6690776","volume":"81","author":"L Hefler","year":"1999","unstructured":"Hefler L, Tempfer C, Heinze G, Mayerhofer K, Breitenecker G, Leodolter S. Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients. Br J Cancer. 1999;81(5):855\u20139.","journal-title":"Br J Cancer"},{"issue":"14","key":"4461_CR2","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1158\/1078-0432.CCR-11-0351","volume":"17","author":"EK Moon","year":"2011","unstructured":"Moon EK, Carpenito C, Sun J, Wang LC, Kapoor V, Predina J. Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor. Clin Cancer Res. 2011;17(14):4719\u201330.","journal-title":"Clin Cancer Res"},{"key":"4461_CR3","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1038\/s41467-021-27108-8","volume":"12","author":"A Rogic","year":"2021","unstructured":"Rogic A, Pant I, Grumolato L, Fernandez-Rodriguez R, Edwards A, Das S. High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer. Nat Commun. 2021;12:6889.","journal-title":"Nat Commun"},{"key":"4461_CR4","doi-asserted-by":"publisher","first-page":"628906","DOI":"10.3389\/fimmu.2021.628906","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang J, Yang X, Yang J, Lu P, Zhao L, et al. Chemokine receptor CCR2b enhanced anti-tumor function of chimeric antigen receptor T cells targeting mesothelin in a non-small-cell lung carcinoma model. Front Immunol. 2021;12:628906.","journal-title":"Front Immunol"},{"issue":"4","key":"4461_CR5","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.3390\/ijms24043129","volume":"24","author":"FF Feigl","year":"2023","unstructured":"Feigl FF, Stahringer A, Peindl M, Dandekar G, Koehl U, Fricke S. Efficient redirection of NK cells by genetic modification with chemokine receptors CCR4 and CCR2B. Int J Mol Sci. 2023;24(4):3129.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4461_CR6","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","volume":"24","author":"KC Barry","year":"2018","unstructured":"Barry KC, Hsu J, Broz ML, Cueto FJ, Binnewies M, Combes AJ. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat Med. 2018;24(8):1178\u201391.","journal-title":"Nat Med"},{"issue":"5","key":"4461_CR7","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher JP, Bonavita E, Chakravarty P, Blees H, Cabeza-Cabrerizo M, Sammicheli S. NK cells stimulate recruitment of cDC1 into the Tumor microenvironment promoting cancer immune control. Cell. 2018;172(5):1022\u201337.","journal-title":"Cell"},{"issue":"4","key":"4461_CR8","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","volume":"44","author":"H Salmon","year":"2016","unstructured":"Salmon H, Idoyaga J, Rahman A, Leboeuf M, Remark R, Jordan S. Expansion and activation of CD103(+) dendritic cell progenitors at the Tumor site enhances Tumor responses to therapeutic PD-L1 and BRAF inhibition. Immunity. 2016;44(4):924\u201338.","journal-title":"Immunity"},{"issue":"8","key":"4461_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41590-018-0145-8","volume":"19","author":"P Michea","year":"2018","unstructured":"Michea P, No\u00ebl F, Zakine E, Czerwinska U, Sirven P, Abouzid O. Adjustment of dendritic cells to the breast-cancer microenvironment is subset-specific. Nat Immunol. 2018;19(8):885\u201397.","journal-title":"Nat Immunol"},{"issue":"1","key":"4461_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40425-018-0446-3","volume":"6","author":"I Truxova","year":"2018","unstructured":"Truxova I, Kasikova L, Hensler M, Skapa P, Laco J, Pecen L. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. J Immunother Cancer. 2018;6(1):139.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"4461_CR11","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/ni1513","volume":"8","author":"A Link","year":"2007","unstructured":"Link A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, Hinz B. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol. 2007;8(11):1255\u201365.","journal-title":"Nat Immunol"},{"issue":"4","key":"4461_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nbt.4086","volume":"36","author":"K Adachi","year":"2018","unstructured":"Adachi K, Kano Y, Nagai T, Okuyama N, Sakoda Y, Tamada K. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat Biotechnol. 2018;36(4):346\u201351.","journal-title":"Nat Biotechnol"},{"issue":"303","key":"4461_CR13","doi-asserted-by":"publisher","first-page":"303ra139","DOI":"10.1126\/scitranslmed.aac5415","volume":"7","author":"DL Porter","year":"2015","unstructured":"Porter DL, Hwang WT, Frey NV, Lacey SF, Shaw PA, Loren AW. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci Transl Med. 2015;7(303):303ra139.","journal-title":"Sci Transl Med."},{"issue":"7","key":"4461_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1084\/jem.20041389","volume":"200","author":"PR Burkett","year":"2004","unstructured":"Burkett PR, Koka R, Chien M, Chai S, Boone DL, Ma A. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J Exp Med. 2004;200(7):825\u201334.","journal-title":"J Exp Med"},{"issue":"5","key":"4461_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1158\/2326-6066.CIR-18-0466","volume":"7","author":"D Alizadeh","year":"2019","unstructured":"Alizadeh D, Wong RA, Yang X, Wang D, Pecoraro JR, Kuo CF. IL15 enhances CAR-T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype. Cancer Immunol Res. 2019;7(5):759\u201372.","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"4461_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1910607","volume":"382","author":"E Liu","year":"2020","unstructured":"Liu E, Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R. Use of CAR-transduced natural killer cells in CD19-positive lymphoid Tumors. N Engl J Med. 2020;382(6):545\u201353.","journal-title":"N Engl J Med"},{"issue":"13","key":"4461_CR17","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1158\/0008-5472.CAN-21-0035","volume":"81","author":"R Ma","year":"2021","unstructured":"Ma R, Lu T, Li Z, Teng KY, Mansour AG, Yu M. An oncolytic virus expressing IL15\/IL15R\u03b1 combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma. Cancer Res. 2021;81(13):3635\u201348.","journal-title":"Cancer Res"},{"issue":"8","key":"4461_CR18","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","volume":"105","author":"JS Miller","year":"2005","unstructured":"Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105(8):3051\u20137.","journal-title":"Blood"},{"issue":"3","key":"4461_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.humimm.2011.12.015","volume":"73","author":"M Luevano","year":"2012","unstructured":"Luevano M, Daryouzeh M, Alnabhan R, Querol S, Khakoo S, Madrigal A. The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation. Hum Immunol. 2012;73(3):248\u201357.","journal-title":"Hum Immunol"},{"key":"4461_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fmed.2015.00093","volume":"2","author":"RS Mehta","year":"2016","unstructured":"Mehta RS, Shpall EJ, Rezvani K. Cord blood as a source of natural killer cells. Front Med. 2016;2:93.","journal-title":"Front Med"},{"issue":"10","key":"4461_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","volume":"22","author":"TJ Laskowski","year":"2022","unstructured":"Laskowski TJ, Biederst\u00e4dt A, Rezvani K. Natural killer cells in antitumour adoptive cell immunotherapy. Nat Rev Cancer. 2022;22(10):557\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"4461_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.5966\/sctm.2012-0084","volume":"2","author":"DA Knorr","year":"2013","unstructured":"Knorr DA, Ni Z, Hermanson D, Hexum MK, Bendzick L, Cooper LJ, et al. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. Stem Cells Transl Med. 2013;2(4):274\u201383.","journal-title":"Stem Cells Transl Med"},{"issue":"568","key":"4461_CR23","doi-asserted-by":"publisher","first-page":"eaa5618","DOI":"10.1126\/scitranslmed.aaz5618","volume":"12","author":"F Cichocki","year":"2020","unstructured":"Cichocki F, Bjordahl R, Gaidarova S, Mahmood S, Abujarour R, Wang H. iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy. Sci Transl Med. 2020;12(568):eaa5618.","journal-title":"Sci Transl Med."},{"issue":"5","key":"4461_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","volume":"18","author":"D Hockemeyer","year":"2016","unstructured":"Hockemeyer D, Jaenisch R. Induced pluripotent stem cells meet genome editing. Cell Stem Cell. 2016;18(5):573\u201386.","journal-title":"Cell Stem Cell"},{"key":"4461_CR25","doi-asserted-by":"publisher","first-page":"841107","DOI":"10.3389\/fimmu.2022.841107","volume":"13","author":"BH Goldenson","year":"2022","unstructured":"Goldenson BH, Hor P, Kaufman DS. iPSC-derived natural killer cell therapies\u2014expansion and targeting. Front Immunol. 2022;13:841107.","journal-title":"Front Immunol"},{"issue":"2","key":"4461_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.stem.2018.06.002","volume":"23","author":"Y Li","year":"2018","unstructured":"Li Y, Hermanson DL, Moriarity BS, Kaufman DS. Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-Tumor activity. Cell Stem Cell. 2018;23(2):181-192.e5.","journal-title":"Cell Stem Cell"},{"key":"4461_CR27","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.1038\/s41467-022-35127-2","volume":"13","author":"F Cichocki","year":"2022","unstructured":"Cichocki F, Bjordahl R, Goodridge JP, Mahmood S, Gaidarova S, Abujarour R. Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma. Nat Commun. 2022;13:7341.","journal-title":"Nat Commun"},{"issue":"1","key":"4461_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2583.2004.00525.x","volume":"14","author":"X Li","year":"2005","unstructured":"Li X, Harrell RA, Handler AM, Beam T, Hennessy K, Fraser MJ Jr. piggyBac internal sequences are necessary for efficient transformation of target genomes. Insect Mol Biol. 2005;14(1):17\u201330.","journal-title":"Insect Mol Biol"},{"issue":"4","key":"4461_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.stemcr.2015.08.015","volume":"5","author":"BA Baghbaderani","year":"2015","unstructured":"Baghbaderani BA, Tian X, Neo BH, Burkall A, Dimezzo T, Sierra G. cGMP-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications. Stem Cell Rep. 2015;5(4):647\u201359.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"4461_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s42003-022-03467-w","volume":"5","author":"Y Wada","year":"2022","unstructured":"Wada Y, Sato T, Hasegawa H, Matsudaira T, Nao N, Coler-Reilly ALG. RAISING is a high-performance method for identifying random transgene integration sites. Commun Biol. 2022;5(1):535.","journal-title":"Commun Biol"},{"issue":"12","key":"4461_CR31","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMp1607591","volume":"375","author":"RL Grossman","year":"2016","unstructured":"Grossman RL, Heath AP, Ferretti V, Varmus HE, Lowy DR, Kibbe WA. Toward a shared vision for cancer genomic data. N Eng J Med. 2016;375(12):1109\u201312.","journal-title":"N Eng J Med"},{"issue":"1\u20132","key":"4461_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0022-1759(94)90147-3","volume":"177","author":"NG Papadopoulos","year":"1994","unstructured":"Papadopoulos NG, Dedoussis GV, Spanakos G, Gritzapis AD, Baxevanis CN, Papamichail M. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. J Immunol Methods. 1994;177(1\u20132):101\u201311.","journal-title":"J Immunol Methods"},{"key":"4461_CR33","doi-asserted-by":"publisher","first-page":"628090","DOI":"10.3389\/fimmu.2021.628090","volume":"12","author":"EJ Loef","year":"2021","unstructured":"Loef EJ, Sheppard HM, Birch NP, Dunbar PR. Live-cell microscopy reveals that human t cells primarily respond Chemokinetically within a CCL19 gradient that induces chemotaxis in dendritic cells. Front Immunol. 2021;12:628090.","journal-title":"Front Immunol"},{"issue":"2","key":"4461_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.imlet.2005.02.016","volume":"99","author":"M Lehner","year":"2005","unstructured":"Lehner M, Morhart P, Stilper A, Holter W. Functional characterization of monocyte-derived dendritic cells generated under serumfree culture conditions. Immunol Lett. 2005;99(2):209\u201316.","journal-title":"Immunol Lett"},{"issue":"7","key":"4461_CR35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382.","journal-title":"Nat Methods"},{"issue":"9","key":"4461_CR36","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K. NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175\u201382.","journal-title":"Blood"},{"issue":"50","key":"4461_CR37","doi-asserted-by":"publisher","first-page":"18171","DOI":"10.1073\/pnas.0508945102","volume":"102","author":"JR Munoz","year":"2005","unstructured":"Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ. Human stem\/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA. 2005;102(50):18171\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4461_CR38","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s12885-021-08205-9","volume":"21","author":"U Jarry","year":"2021","unstructured":"Jarry U, Bosto\u00ebn M, Pineau R, Chaillot L, Mennessier V, Montagne P, et al. Orthotopic model of lung cancer: isolation of bone micro-metastases after tumor escape from Osimertinib treatment. BMC Cancer. 2021;21(1):530.","journal-title":"BMC Cancer"},{"issue":"5","key":"4461_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri2297","volume":"8","author":"R F\u00f6rster","year":"2008","unstructured":"F\u00f6rster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol. 2008;8(5):362\u201371.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"4461_CR40","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/CJI.0b013e3181ee6675","volume":"33","author":"JA Craddock","year":"2010","unstructured":"Craddock JA, Lu A, Bear A, Pule M, Brenner MK, Rooney CM. Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b. J Immunother. 2010;33(8):780\u20138.","journal-title":"J Immunother"},{"issue":"1","key":"4461_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8(1):34\u201347.","journal-title":"Nat Rev Immunol"},{"key":"4461_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nri1901","volume":"6","author":"T Waldmann","year":"2006","unstructured":"Waldmann T. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol. 2006;6:595\u2013601.","journal-title":"Nat Rev Immunol"},{"key":"4461_CR43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nri1199","volume":"3","author":"D Raulet","year":"2003","unstructured":"Raulet D. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003;3:781\u201390.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4461_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.devcel.2020.02.016","volume":"53","author":"C Dege","year":"2020","unstructured":"Dege C, Fegan KH, Creamer JP, Berrien-Elliott MM, Luff SA, Kim D. Potently cytotoxic natural killer cells initially emerge from erythro-myeloid progenitors during mammalian development. Developmental cell. 2020;53(2):229-239e.7.","journal-title":"Developmental cell."},{"issue":"12","key":"4461_CR45","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.humimm.2013.08.281","volume":"74","author":"W Boukouaci","year":"2013","unstructured":"Boukouaci W, Al-Daccak R, Dulphy N, Lauden L, Amokrane K, Fortier C. Soluble MICA-NKG2D interaction upregulates IFN-\u03b3 production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease. Hum Immunol. 2013;74(12):1536\u201341.","journal-title":"Hum Immunol"},{"issue":"28","key":"4461_CR46","doi-asserted-by":"publisher","first-page":"45432","DOI":"10.18632\/oncotarget.17139","volume":"8","author":"A Kol","year":"2017","unstructured":"Kol A, Scheltinga A, Pool M, Gerdes C, Vries E, Jong S. ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells. Oncotarget. 2017;8(28):45432\u201346.","journal-title":"Oncotarget"},{"key":"4461_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molimm.2019.02.014","volume":"109","author":"XY Mu","year":"2019","unstructured":"Mu XY, Wang RJ, Yao ZX, Zheng Z, Jiang JT, Tan MY. RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment. Mol Immunol. 2019;109:140\u20138.","journal-title":"Mol Immunol"},{"issue":"1","key":"4461_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39(1):1\u201310.","journal-title":"Immunity"},{"issue":"3","key":"4461_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cytogfr.2013.03.001","volume":"24","author":"I Comerford","year":"2013","unstructured":"Comerford I, Harata-Lee Y, Bunting MD, Gregor C, Kara EE, McColl SR. A myriad of functions and complex regulation of the CCR7\/CCL19\/CCL21 chemokine axis in the adaptive immune system. Cytokine Growth Factor Rev. 2013;24(3):269\u201383.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"4461_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","volume":"22","author":"AM Gocher","year":"2022","unstructured":"Gocher AM, Workman CJ, Vignali DAA. Interferon-\u03b3: teammate or opponent in the tumour microenvironment? Nat Rev Immunol. 2022;22(3):158\u201372.","journal-title":"Nat Rev Immunol"},{"issue":"5209","key":"4461_CR51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.7716543","volume":"268","author":"M Colonna","year":"1995","unstructured":"Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 1995;268(5209):405\u20138.","journal-title":"Science"},{"issue":"5","key":"4461_CR52","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.4049\/jimmunol.155.5.2306","volume":"155","author":"A D'andrea","year":"1995","unstructured":"D\u2019andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1 A natural killer cell receptor for HLA-B allotypes. J Immunol. 1995;155(5):2306\u201310.","journal-title":"J Immunol"},{"issue":"2","key":"4461_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0167-5699(96)80585-8","volume":"17","author":"LL Lanier","year":"1996","unstructured":"Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today. 1996;17(2):86\u201391.","journal-title":"Immunol Today"},{"issue":"2\u20134","key":"4461_CR54","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0171-2985(11)80559-0","volume":"193","author":"A Jahnke","year":"1995","unstructured":"Jahnke A, Johnson JP. Intercellular adhesion molecule 1 (ICAM-1) is synergistically activated by TNF-alpha and IFN-gamma responsive sites. Immunobiology. 1995;193(2\u20134):305\u201314.","journal-title":"Immunobiology"},{"issue":"10","key":"4461_CR55","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1182\/blood.V91.10.3850","volume":"91","author":"S Nagashima","year":"1998","unstructured":"Nagashima S, Mailliard R, Kashii Y, Reichert TE, Herberman RB, Robbins P, et al. Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo. Blood. 1998;91(10):3850\u201361.","journal-title":"Blood"},{"issue":"1","key":"4461_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1084\/jem.20082013","volume":"206","author":"ND Huntington","year":"2008","unstructured":"Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med. 2008;206(1):25\u201334.","journal-title":"J Exp Med"},{"issue":"10","key":"4461_CR57","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4252\/wjsc.v11.i10.729","volume":"11","author":"C Steichen","year":"2019","unstructured":"Steichen C, Hannoun Z, Luce E, Hauet T, Dubart-Kupperschmitt A. Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications. World J Stem Cells. 2019;11(10):729\u201347.","journal-title":"World J Stem Cells"},{"issue":"9","key":"4461_CR58","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41588-022-01147-3","volume":"54","author":"FJ Rouhani","year":"2022","unstructured":"Rouhani FJ, Zou X, Danecek P, Badja C, Amarante TD, Koh G. Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells. Nat Genet. 2022;54(9):1406\u201316.","journal-title":"Nat Genet"},{"issue":"19","key":"4461_CR59","doi-asserted-by":"publisher","first-page":"9568","DOI":"10.1158\/0008-5472.CAN-06-2707","volume":"67","author":"N Tsuchiya","year":"2007","unstructured":"Tsuchiya N, Ochiai M, Nakashima K, Ubagai T, Sugimura T, Nakagama H. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. Cancer Res. 2007;67(19):9568\u201376.","journal-title":"Cancer Res"},{"issue":"6","key":"4461_CR60","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/neuonc\/noz038","volume":"21","author":"L Yu","year":"2019","unstructured":"Yu L, Xu J, Liu J, Zhang H, Sun C, Wang Q. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients. Neuro Oncol. 2019;21(6):742\u201354.","journal-title":"Neuro Oncol"},{"key":"4461_CR61","doi-asserted-by":"publisher","first-page":"734593","DOI":"10.3389\/fonc.2021.734593","volume":"11","author":"G Li","year":"2021","unstructured":"Li G, Zhang Q, Han Z, Zhu Y, Shen H, Liu Z, et al. IL-7 and CCR2b Co-expression-mediated enhanced car-t survival and infiltration in solid Tumors. Front Oncol. 2021;11:734593.","journal-title":"Front Oncol"},{"issue":"4","key":"4461_CR62","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1158\/0008-5472.CAN-11-1792","volume":"72","author":"AM Lesokhin","year":"2012","unstructured":"Lesokhin AM, Hohl TM, Kitano S, Cortez C, Hirschhorn-Cymerman D, Avogadri F. Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. Cancer Res. 2012;72(4):876\u201386.","journal-title":"Cancer Res"},{"issue":"22","key":"4461_CR63","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1158\/0008-5472.CAN-16-0984","volume":"76","author":"PL Loyher","year":"2016","unstructured":"Loyher PL, Rochefort J, Chanville C, Hamon P, Lescaille G, Bertolus C. CCR2 influences T regulatory cell migration to Tumors and serves as a biomarker of cyclophosphamide sensitivity. Cancer Res. 2016;76(22):6483\u201394.","journal-title":"Cancer Res"},{"issue":"9","key":"4461_CR64","doi-asserted-by":"publisher","first-page":"1470729","DOI":"10.1080\/2162402X.2018.1470729","volume":"7","author":"JG Grossman","year":"2018","unstructured":"Grossman JG, Nywening TM, Belt BA, Panni RZ, Krasnick BA, DeNardo DG. Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer. Oncoimmunology. 2018;7(9):1470729.","journal-title":"Oncoimmunology"},{"issue":"5","key":"4461_CR65","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","volume":"211","author":"MZ Noman","year":"2014","unstructured":"Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P. PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014;211(5):781\u201390.","journal-title":"J Exp Med"},{"issue":"12","key":"4461_CR66","doi-asserted-by":"publisher","first-page":"1247135","DOI":"10.1080\/2162402X.2016.1247135","volume":"5","author":"C Lu","year":"2016","unstructured":"Lu C, Redd PS, Lee JR, Savage N, Liu K. The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells. Oncoimmunology. 2016;5(12):1247135.","journal-title":"Oncoimmunology"},{"issue":"1","key":"4461_CR67","doi-asserted-by":"publisher","first-page":"000450","DOI":"10.1136\/jitc-2019-000450","volume":"8","author":"KP Fabian","year":"2020","unstructured":"Fabian KP, Padget MR, Donahue RN, Solocinski K, Robbins Y, Allen CT. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations. J Immunother Cancer. 2020;8(1):000450.","journal-title":"J Immunother Cancer"},{"key":"4461_CR68","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","volume":"39","author":"M Cabeza-Cabrerizo","year":"2021","unstructured":"Cabeza-Cabrerizo M, Cardoso A, Minutti CM, Costa M. Reis, Sousa C. Dendritic Cells Revisited Annu Rev Immunol. 2021;39:131\u201366.","journal-title":"Dendritic Cells Revisited Annu Rev Immunol"},{"issue":"2","key":"4461_CR69","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","volume":"30","author":"EW Roberts","year":"2016","unstructured":"Roberts EW, Broz ML, Binnewies M, Headley MB, Nelson AE, Wolf DM. Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for Tumor antigen trafficking and priming of T cell immunity in melanoma. Cancer Cell. 2016;30(2):324\u201336.","journal-title":"Cancer Cell"},{"issue":"6","key":"4461_CR70","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1084\/jem.20092140","volume":"207","author":"SL Jongbloed","year":"2010","unstructured":"Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med. 2010;207(6):1247\u201360.","journal-title":"J Exp Med"},{"issue":"11","key":"4461_CR71","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","volume":"4","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher JP, Sousa CR. The role of type 1 conventional dendritic cells in cancer immunity. Trends Cancer. 2018;4(11):784\u201392.","journal-title":"Trends Cancer"},{"issue":"8","key":"4461_CR72","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1084\/jem.20021836","volume":"197","author":"R Koka","year":"2003","unstructured":"Koka R, Burkett PR, Chien M, Chai S, Chan F, Lodolce JP, et al. Interleukin (IL)-15R\u03b1-deficient natural killer cells survive in normal but not IL-15R\u03b1-deficient mice. J Exp Med. 2003;197(8):977\u201384.","journal-title":"J Exp Med"},{"issue":"2","key":"4461_CR73","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1182\/blood-2003-12-4187","volume":"105","author":"H Kobayashi","year":"2005","unstructured":"Kobayashi H, Dubois S, Sato N, Sabzevari H, Sakai Y, Waldmann TA, et al. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood. 2005;105(2):721\u20137.","journal-title":"Blood"},{"issue":"5","key":"4461_CR74","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.immuni.2009.09.017","volume":"31","author":"E Mortier","year":"2009","unstructured":"Mortier E, Advincula R, Kim L, Chmura S, Barrera J, Reizis B. Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets. Immunity. 2009;31(5):811\u201322.","journal-title":"Immunity"},{"issue":"5164","key":"4461_CR75","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell Jr","year":"1994","unstructured":"Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264(5164):1415\u201321.","journal-title":"Science"},{"issue":"5168","key":"4461_CR76","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1126\/science.8016643","volume":"265","author":"V Steimle","year":"1994","unstructured":"Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 1994;265(5168):106\u20139.","journal-title":"Science"},{"issue":"1","key":"4461_CR77","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0952-7915(99)80014-4","volume":"11","author":"K Fr\u00fch","year":"1999","unstructured":"Fr\u00fch K, Yang Y. Antigen presentation by MHC class I and its regulation by interferon gamma. Curr Opin Immunol. 1999;11(1):76\u201381.","journal-title":"Curr Opin Immunol"},{"key":"4461_CR78","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fimmu.2017.00391","volume":"8","author":"A Aquino-L\u00f3pez","year":"2017","unstructured":"Aquino-L\u00f3pez A, Senyukov VV, Vlasic Z, Kleinerman ES, Lee DA. Interferon gamma induces changes in natural killer (NK) cell ligand expression and alters NK cell-mediated lysis of pediatric cancer cell lines. Front Immunol. 2017;8:391.","journal-title":"Front Immunol"},{"key":"4461_CR79","doi-asserted-by":"publisher","first-page":"290728","DOI":"10.3389\/fimmu.2017.01124","volume":"8","author":"S Paul","year":"2017","unstructured":"Paul S, Lal G. The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy. Front Immunol. 2017;8:290728.","journal-title":"Front Immunol"},{"issue":"6669","key":"4461_CR80","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35869","volume":"391","author":"VM Braud","year":"1998","unstructured":"Braud VM, Allan DSJ, O\u2019Callaghan CA, S\u00f6derstr\u00f6m K, D\u2019Andrea A, Ogg GS, et al. HLA-E binds to natural killer cell receptors CD94\/NKG2A. B and C Nat. 1998;391(6669):795\u20139.","journal-title":"B and C Nat"},{"issue":"9","key":"4461_CR81","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","volume":"95","author":"N Lee","year":"1998","unstructured":"Lee N, Llano M, Carretero M, Ishitani A, Navarro F, L\u00f3pez-Botet M. HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A. Proc Natl Acad Sci USA. 1998;95(9):5199\u2013204.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"4461_CR82","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1093\/emboj\/18.15.4250","volume":"18","author":"M Val\u00e9s-G\u00f3mez","year":"1999","unstructured":"Val\u00e9s-G\u00f3mez M, Reyburn HT, Erskine RA, L\u00f3pez-Botet M, Strominger JL. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94\/NKG2-A and the activating receptor CD94\/NKG2-C to HLA-E. EMBO J. 1999;18(15):4250\u201360.","journal-title":"EMBO J"},{"issue":"7","key":"4461_CR83","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.cell.2018.11.048","volume":"175","author":"JB Haanen","year":"2018","unstructured":"Haanen JB, Cerundolo V. NKG2A, a new kid on the immune checkpoint block. Cell. 2018;175(7):1720\u20132.","journal-title":"Cell"},{"issue":"5","key":"4461_CR84","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41571-019-0182-8","volume":"16","author":"BC Creelan","year":"2019","unstructured":"Creelan BC, Antonia SJ. The NKG2A immune checkpoint - a new direction in cancer immunotherapy. Nat Rev Clin Oncol. 2019;16(5):277\u20138.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"4461_CR85","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","volume":"175","author":"P Andr\u00e9","year":"2018","unstructured":"Andr\u00e9 P, Denis C, Soulas C, Bourbon-Caillet C, Lopez J, Arnoux T. Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells. Cell. 2018;175(7):1731-1743e.13.","journal-title":"Cell"},{"issue":"5","key":"4461_CR86","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/JCI123955","volume":"129","author":"T Kamiya","year":"2019","unstructured":"Kamiya T, Seow SV, Wong D, Robinson M, Campana D. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells. J Clin Invest. 2019;129(5):2094\u2013106.","journal-title":"J Clin Invest"},{"key":"4461_CR87","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fimmu.2015.00266","volume":"6","author":"M Carlsten","year":"2015","unstructured":"Carlsten M, Childs RW. Genetic manipulation of NK cells for cancer immunotherapy: techniques and clinical implications. Front Immunol. 2015;6:266.","journal-title":"Front Immunol"},{"issue":"3","key":"4461_CR88","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/stcltm\/szad087","volume":"13","author":"A Maia","year":"2024","unstructured":"Maia A, Tarannum M, Romee R. Genetic manipulation approaches to enhance the clinical application of NK cell-based immunotherapy. Stem Cells Transl Med. 2024;13(3):230\u201342.","journal-title":"Stem Cells Transl Med"},{"key":"4461_CR89","doi-asserted-by":"publisher","first-page":"1141208","DOI":"10.3389\/fimmu.2023.1141208","volume":"14","author":"P Sindaco","year":"2023","unstructured":"Sindaco P, Pandey H, Isabelle C, Chakravarti N, Brammer JE, Porcu P, et al. The role of interleukin-15 in the development and treatment of hematological malignancies. Front Immunol. 2023;14:1141208.","journal-title":"Front Immunol"},{"issue":"8","key":"4461_CR90","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00262-021-03126-9","volume":"71","author":"E Cluff","year":"2022","unstructured":"Cluff E, Magdaleno CC, Fernandez E, House T, Swaminathan S, Varadaraj A, et al. Hypoxia-inducible factor-1 alpha expression is induced by IL-2 via the PI3K\/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded NK cells. Cancer Immunol Immunother. 2022;71(8):1989\u20132005.","journal-title":"Cancer Immunol Immunother"},{"key":"4461_CR91","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.coph.2016.06.009","volume":"29","author":"SM Hatfield","year":"2016","unstructured":"Hatfield SM, Sitkovsky M. A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1\u03b1 driven immunosuppression and improve immunotherapies of cancer. Curr Opin Pharmacol. 2016;29:90\u20136.","journal-title":"Curr Opin Pharmacol"},{"key":"4461_CR92","doi-asserted-by":"publisher","first-page":"e73699","DOI":"10.7554\/eLife.73699","volume":"11","author":"AM Chambers","year":"2022","unstructured":"Chambers AM, Lupo KB, Wang J, Cao J, Utturkar S, Lanman N, Matosevic S. Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors. Elife. 2022;11:e73699.","journal-title":"Elife"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04461-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04461-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04461-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:29:43Z","timestamp":1757248183000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04461-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4461"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04461-9","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human samples and animal studies were approved by the committee of ethics on experimentation in HEALIOS K.K. Informed consent was obtained from the donors at the providing institution, with an explanation that the cells might be shared with other research institutions for medical research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"K.T. is CSO of HEALIOS K.K.; Y.F., K.K., Yu.To., K.M., M.H., Ka.Sa., Ko.Sa., Y.N., S.W., Y.H., N.U., Y.I., K.G., Y.S., H.M., T.S., T.O., N.T., M.Y., Yu.Ta., T.H., F.N., H.K., and K.T. are employees of HEALIOS K.K.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}